Placenta
Volume 31 , Pages S47-S53 , March 2010

IFPA Award in Placentology Lecture: Complicated interactions between genes and the environment in placentation, pregnancy outcome and long term health

  • C.T. Roberts

      Affiliations

    • Corresponding Author InformationTel.: +61 8 83033118; fax: +61 8 83034099.

,Accepted 4 January 2010.

References 

  1. Khong TY, Liddell HS, Robertson WB. Defective haemochorial placentation as a cause of miscarriage: a preliminary study. Br J Obstet Gynaecol. 1987;94:649–655
  2. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol. 1986;93:1049–1059
  3. Dommisse J, Tiltman AJ. Placental bed biopsies in placental abruption. Br J Obstet Gynaecol. 1992;99:651–654
  4. Kim YM, Bujold E, Chaiworapongsa T, Gomez R, Yoon BH, Thaler HT, et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 2003;189:1063–1069
  5. Kim YM, Chaiworapongsa T, Gomez R, Bujold E, Yoon BH, Rotmensch S, et al. Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol. 2002;187:1137–1142
  6. Smith GC, Crossley JA, Aitken DA, Pell JP, Cameron AD, Connor JM, et al. First-trimester placentation and the risk of antepartum stillbirth. JAMA. 2004;292:2249–2254
  7. Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2009;30:473–482
  8. Redman CWG, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response – a review. Placenta. 2003;24:S21–S27
  9. Mayhew TM, Wijesekara J, Baker PN, Ong SS. Morphometric evidence that villous development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by pre-eclampsia. Placenta. 2004;25:829–833
  10. Teasdale F, Jean-Jacques G. Intrauterine growth retardation: morphometry of the microvillous membrane of the human placenta. Placenta. 1988;9:47–55
  11. Teasdale F. Histomorphometry of the human placenta in maternal preeclampsia. Am J Obstet Gynecol. 1985;152:25–31
  12. Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Pre-eclampsia and fetal growth restriction: how morphometrically different is the placenta?. Placenta. 2006;27:727–734
  13. Mayhew TM, Ohadike C, Baker PN, Crocker IP, Mitchell C, Ong SS. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta. 2003;24:219–226
  14. Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF beta, IGF-II and IGFBP-1. Exp Cell Res. 1995;217:419–427
  15. Hamilton GS, Lysiak JJ, Han VK, Lala PK. Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res. 1998;244:147–156
  16. Han VK, Bassett N, Walton J, Challis JR. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab. 1996;81:2680–2693
  17. Han VK, Carter AM. Spatial and temporal patterns of expression of messenger RNA for insulin-like growth factors and their binding proteins in the placenta of man and laboratory animals. Placenta. 2000;21:289–305
  18. Pringle KG, Roberts CT. New light on early post-implantation pregnancy in the mouse: roles for insulin-like growth factor-II (IGF-II)?. Placenta. 2007;28:286–297
  19. Lopez MF, Dikkes P, Zurakowski D, Villa-Komaroff L. Insulin-like growth factor II affects the appearance and glycogen content of glycogen cells in the murine placenta. Endocrinology. 1996;137:2100–2108
  20. Leach RE, Kilburn B, Wang J, Liu Z, Romero R, Armant DR. Heparin-binding EGF-like growth factor regulates human extravillous cytotrophoblast development during conversion to the invasive phenotype. Dev Biol. 2004;266:223–237
  21. Leach RE, Romero R, Kim YM, Chaiworapongsa T, Kilburn B, Das SK, et al. Pre-eclampsia and expression of heparin-binding EGF-like growth factor. The Lancet. 2002;360:1215–1219
  22. Irving JA, Lysiak JJ, Graham CH, Hearn S, Han VK, Lala PK. Characteristics of trophoblast cells migrating from first trimester chorionic villus explants and propagated in culture. Placenta. 1995;16:413–433
  23. Ferretti C, Bruni L, Dangles-Marie V, Pecking AP, Bellet D. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum Reprod Update. 2007;13:121–141
  24. Fitzgerald JS, Busch S, Wengenmayer T, Foerster K, de la Motte T, Poehlmann TG, et al. Signal transduction in trophoblast invasion. Chem Immunol Allergy. 2005;88:181–199
  25. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response – a review. Placenta. 2003;24(Suppl. A):S21–S27
  26. Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?. Hum Reprod Update. 2009;15:517–535
  27. Robertson SA, Bromfield JJ, Tremellen KP. Seminal ‘priming’ for protection from pre-eclampsia – a unifying hypothesis. J Reprod Immunol. 2003;59:253–265
  28. Kho EM, McCowan LME, North RA, Roberts CT, Chan E, Black MA, et al. Duration of sexual relationship and its effect on preeclampsia and small for gestational age perinatal outcome. J Reprod Immunol. 2009;82:66–73
  29. Sargent IL, Borzychowski AM, Redman CWG. NK cells and human pregnancy – an inflammatory view. Trends Immunol. 2006;27:399–404
  30. Hiby SE, Walker JJ, O'Shaughnessy KM, Redman CWG, Carrington M, Trowsdale J, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med. 2004;200:957–965
  31. Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet. 1993;341:938–941
  32. Roberts CT, Sohlstrom A, Kind KL, Earl RA, Khong TY, Robinson JS, et al. Maternal food restriction reduces the exchange surface area and increases the barrier thickness of the placenta in the guinea-pig. Placenta. 2001;22:177–185
  33. Roberts CT, Sohlstrom A, Kind KL, Grant PA, Earl RA, Robinson JS, et al. Altered placental structure induced by maternal food restriction in guinea pigs: a role for circulating IGF-II and IGFBP-2 in the mother?. Placenta. 2001;22:S77–S82
  34. Roberts CT, Kind KL, Earl RA, Grant PA, Robinson JS, Sohlstrom A, et al. Circulating insulin-like growth factor (IGF)-I and IGF binding proteins -1 and -3 and placental development in the guinea-pig. Placenta. 2002;23:763–770
  35. Jones HN, Powell TL, Jansson T. Regulation of placental nutrient transport – a review. Placenta. 2007;28:763–774
  36. Barker DJ. The developmental origins of adult disease. J Am Coll Nutr. 2004;23:588S–595S
  37. Kajantie E, Osmond C, Barker DJ, Forsen T, Phillips DI, Eriksson JG. Size at birth as a predictor of mortality in adulthood: a follow-up of 350 000 person-years. Int J Epidemiol. 2005;34:655–663
  38. Risnes KR, Romundstad PR, Nilsen TIL, Eskild A, Vatten LJ. Placental weight relative to birth weight and long-term cardiovascular mortality: findings from a cohort of 31,307 men and women. Am J Epidemiol. 2009;170:622–631
  39. Eriksson JG, Kajantie E, Osmond C, Thornburg K, Barker DJ. Boys live dangerously in the womb. Am J Hum Biol. 2009;
  40. Yampolsky M, Salafia CM, Shlakhter O, Haas D, Eucker B, Thorp J. Modeling the variability of shapes of a human placenta. Placenta. 2008;29:790–797
  41. Kajantie E, Thornburg K, Eriksson JG, Osmond L, Barker DJ. In preeclampsia, the placenta grows slowly along its minor axis. Int J Dev Biol. 2009;
  42. Paneth N. The impressionable fetus? Fetal life and adult health. Am J Public Health. 1994;84:1372–1374
  43. Paneth N, Susser M. Early origin of coronary heart disease (The “Barker hypothesis”): hypotheses, no matter how intriguing, need rigorous attempts at refutation. BMJ. 1995;310:411–412
  44. Williams S, Poulton R. Twins and maternal smoking: ordeals for the fetal origins hypothesis? A cohort study. BMJ. 1999;318:897–900
  45. Kajantie E, Eriksson JG, Osmond C, Thornburg K, Barker DJP. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the helsinki birth cohort study. Stroke. 2009;40:1176–1180
  46. Hofman PL, Regan F, Jackson WE, Jefferies C, Knight DB, Robinson EM, et al. Premature birth and later insulin resistance. N Engl J Med. 2004;351:2179–2186
  47. Simeoni U, Barker DJ. Offspring of diabetic pregnancy: long-term outcomes. Semin Fetal Neonatal Med. 2009;14:119–124
  48. Bellamy L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335:974
  49. Brown DW, Dueker N, Jamieson DJ, Cole JW, Wozniak MA, Stern BJ, et al. Preeclampsia and the risk of ischemic stroke among young women: results from the stroke prevention in young women study. Stroke. 2006;37:1055–1059
  50. Davey Smith G, Sterne J, Tynelius P, Lawlor DA, Rasmussen F. Birth weight of offspring and subsequent cardiovascular mortality of the parents. Epidemiology. 2005;16:563–569
  51. Davey Smith G, Hypponen E, Power C, Lawlor DA. Offspring birth weight and parental mortality: prospective observational study and meta-analysis. Am J Epidemiol. 2007;166:160–169
  52. Jaquet D, Swaminathan S, Alexander GR, Czernichow P, Collin D, Salihu HM, et al. Significant paternal contribution to the risk of small for gestational age. BJOG: Int J Obstetrics Gynaecol. 2005;112:153–159
  53. Zetterstrom K, Lindeberg S, Haglund B, Magnuson A, Hanson U. Being born small for gestational age increases the risk of severe pre-eclampsia. BJOG: Int J Obstetrics Gynaecol. 2007;114:319–324
  54. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. The Lancet. 2005;365:785–799
  55. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330:565
  56. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ. 1998;316:1343–1347
  57. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J, et al. Paternal and maternal components of the predisposition to preeclampsia. New Engl J Med. 2001;344:867–872
  58. Haig D. Altercation of generations: genetic conflicts of pregnancy. Am J Reprod Immunol. 1996;35:226–232
  59. Petry CJ, Ong KK, Dunger DB. Does the fetal genotype affect maternal physiology during pregnancy?. Trends Mol Med. 2007;13:414–421
  60. Takimoto-Ohnishi E, Saito T, Ishida J, Ohnishi J, Sugiyama F, Yagami K-I, et al. Differential roles of renin and angiotensinogen in the feto-maternal interface in the development of complications of pregnancy. Mol Endocrinol. 2005;19:1361–1372
  61. Takimoto E, Ishida J, Sugiyama F, Horiguchi H, Murakami K, Fukamizu A. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science. 1996;274:995–998
  62. Adkins RM, Krushkal J, Klauser CK, Magann EF, Morrison JC, Somes G. Association between small for gestational age and paternally inherited 5′ insulin haplotypes. Int J Obes. 2007;32:372–380
  63. Sandhu MS, Gibson JM, Heald AH, Dunger DB, Wareham NJ. Low circulating IGF-II concentrations predict weight gain and obesity in humans. Diabetes. 2003;52:1403–1408
  64. O'Dell SD, Miller GJ, Cooper JA, Hindmarsh PC, Pringle PJ, Ford H, et al. Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males. Int J Obes Relat Metab Disord. 1997;21:822–825
  65. Paquette J, Giannoukakis N, Polychronakos C, Vafiadis P, Deal C. The INS 5′ variable number of tandem repeats is associated with IGF2 expression in humans. J Biol Chem. 1998;273:14158–14164
  66. Cross JC, Baczyk D, Dobric N, Hemberger M, Hughes M, Simmons DG, et al. Genes, development and evolution of the placenta. Placenta. 2003;24:123–130
  67. Wang X, Zuckerman B, Pearson C, Kaufman G, Chen C, Wang G, et al. Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA. 2002;287:195–202
  68. Agnihotri B, Antonisamy B, Priya G, Fall CH, Raghupathy P. Trends in human birth weight across two successive generations. Indian J Pediatr. 2008;75:111–117
  69. Conti J, Abraham S, Taylor A. Eating behavior and pregnancy outcome. J Psychosomatic Res. 1998;44:465–477
  70. Suh JR, Herbig AK, Stover PJ. New perspectives on folate catabolism. Annu Rev Nutr. 2001;21:255–282
  71. Furness DLF, Fenech MF, Khong YT, Romero R, Dekker GA. One-carbon metabolism enzyme polymorphisms and uteroplacental insufficiency. Am J Obstet Gynecol. 2008;199:276.e1–276.e8
  72. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266–281
  73. Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J Clin Endocrinol Metab. 2007;92:3517–3522
  74. Zhang C, Qiu C, Hu FB, David RM, van Dam RM, Bralley A, et al. Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS ONE. 2008;3:e3753
  75. Merewood A, Mehta SD, Chen TC, Bauchner H, Holick MF. Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab. 2009;94:940–945
  76. Zehnder D, Evans KN, Kilby MD, Bulmer JN, Innes BA, Stewart PM, et al. The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am J Pathol. 2002;161:105–114
  77. Zhong Y, Cahill AG, Macones GA, Zhu F, Odibo AO. The association between prepregnancy maternal body mass index and preterm delivery. Am J Perinatol. 2009;
  78. Rasweiler JJ. Development of the discoidal hemochorial placenta in the black mastiff bat, molossus ater: evidence for a role of maternal endothelial cells in the control of trophoblastic growth. Am J Anat. 1991;191:185–207
  79. Rasweiler JJ. Spontaneous decidual reactions and menstruation in the black mastiff bat, molossus ater. Am J Anat. 1991;191:1–22
  80. Robillard P-Y, Hulsey TC, Dekker GA, Chaouat G. Preeclampsia and human reproduction: an essay of a long term reflection. J Reprod Immunol. 2003;59:93–100
  81. Egund N, Carter AM. Uterine and placental circulation in the guinea-pig: an angiographic study. J Reprod Fertil. 1974;40:401–410
  82. Seidl DC, Hughes HC, Bertolet R, Lang CM. True pregnancy toxemia (preeclampsia) in the guinea pig (Cavia porcellus). Lab Anim Sci. 1979;29:472–478
  83. Golden JG, Hughes HC, Lang CM. Experimental toxemia in the pregnant guinea pig (Cavia porcellus). Lab Anim Sci. 1980;30:174–179
  84. Carter A, Enders A. Comparative aspects of trophoblast development and placentation. Reprod Biol Endocrinol. 2004;2:46
  85. Roberts CT, Breed WG. Embryonic-maternal cell interactions at implantation in the fat-tailed dunnart, a dasyurid marsupial. Anat Rec. 1994;240:59–76
  86. Menino AR, Hogan A, Schultz GA, Novak S, Dixon W, Foxcroft GH. Expression of proteinases and proteinase inhibitors during embryo-uterine contact in the pig. Dev Genet. 1997;21:68–74

PII: S0143-4004(10)00002-0

doi: 10.1016/j.placenta.2010.01.001

Placenta
Volume 31 , Pages S47-S53 , March 2010

Article Tools

* Image Usage & Resolution